177 related articles for article (PubMed ID: 33461148)
21. Design, Synthesis and Biological Evaluation of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Phenylamino-1,3,5-triazine Scaffold.
Kaitoh K; Nakatsu A; Mori S; Kagechika H; Hashimoto Y; Fujii S
Chem Pharm Bull (Tokyo); 2019; 67(6):566-575. PubMed ID: 31155562
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
23. New 2-Imino-2H-Chromene-3(N-aryl)carboxamides as Potential Cytotoxic Agents.
Gill RK; Kumari J; Bariwal J
Anticancer Agents Med Chem; 2017; 17(1):85-92. PubMed ID: 26961315
[TBL] [Abstract][Full Text] [Related]
24. Prospecting for cytotoxic and antiprotozoal 4-aryl-4H-chromenes and 10-aryldihydropyrano[2,3-f]chromenes.
Martin EF; Mbaveng AT; de Moraes MH; Kuete V; Biavatti MW; Steindel M; Efferth T; Sandjo LP
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800100. PubMed ID: 30137687
[TBL] [Abstract][Full Text] [Related]
25. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.
Roy T; Boateng ST; Banang-Mbeumi S; Singh PK; Basnet P; Chamcheu RN; Ladu F; Chauvin I; Spiegelman VS; Hill RA; Kousoulas KG; Nagalo BM; Walker AL; Fotie J; Murru S; Sechi M; Chamcheu JC
Bioorg Chem; 2021 Feb; 107():104595. PubMed ID: 33450548
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
28. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Lamie PF; El-Kalaawy AM; Abdel Latif NS; Rashed LA; Philoppes JN
Eur J Med Chem; 2021 Mar; 214():113222. PubMed ID: 33545637
[TBL] [Abstract][Full Text] [Related]
29. Exploitation of new chalcones and 4H-chromenes as agents for cancer treatment.
Pontes O; Costa M; Santos F; Sampaio-Marques B; Dias T; Ludovico P; Baltazar F; Proença F
Eur J Med Chem; 2018 Sep; 157():101-114. PubMed ID: 30081238
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives.
Zaher AF; Abuel-Maaty SM; El-Nassan HB; Amer SA; Abdelghany TM
J Enzyme Inhib Med Chem; 2016; 31(sup4):145-153. PubMed ID: 27590401
[TBL] [Abstract][Full Text] [Related]
32. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Zhao J; Crogan-Grundy C; Xu L; Lamothe S; Gourdeau H; Denis R; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2007 Jun; 50(12):2858-64. PubMed ID: 17497765
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Antiproliferative Activity and Molecular Docking Analysis of Both Enantiomerically Pure Decursin Derivatives as Anticancer Agents.
Ahn J; Hwang HH; Jung SY; Lee JY; Kim C; Choi HM; Gwon MJ; Kim MJ; Kwon Y; Woo J; Park B; Ko SG; Lee JY
Chem Pharm Bull (Tokyo); 2024 May; 72(5):498-506. PubMed ID: 38735699
[TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative and apoptotic effects of the derivatives from 4-aryl-4H-chromene family on human leukemia K562 cells.
Aryapour H; Mahdavi M; Mohebbi SR; Zali MR; Foroumadi A
Arch Pharm Res; 2012 Sep; 35(9):1573-82. PubMed ID: 23054714
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, estrogen receptor binding affinity and molecular docking of pyrimidine-piperazine-chromene and -quinoline conjugates.
Parveen I; Ahmed N; Idrees D; Khan P; Hassan MI
Bioorg Med Chem Lett; 2017 Sep; 27(18):4493-4499. PubMed ID: 28797797
[TBL] [Abstract][Full Text] [Related]
38. Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cells.
Lima CF; Costa M; Proença MF; Pereira-Wilson C
Eur J Pharm Sci; 2015 May; 72():34-45. PubMed ID: 25746954
[TBL] [Abstract][Full Text] [Related]
39. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
